FDA.reportPublic FDA data

Application 207516

Type
ANDA
Sponsor
HANGZHOU BINJIANG

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RISEDRONATE SODIUMRISEDRONATE SODIUMTABLET;ORAL35MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60723-041Risedronate SodiumRisedronate SodiumHangzhou Minsheng Binjiang Pharmaceutical CO., LtdANDACurrent
60723-041Risedronate SodiumRisedronate SodiumHangzhou Minsheng Binjiang Pharmaceutical CO., LtdANDACurrent
60723-041Risedronate SodiumRisedronate SodiumHangzhou Minsheng Binjiang Pharmaceutical CO., LtdANDACurrent
60723-041Risedronate SodiumRisedronate SodiumHangzhou Minsheng Binjiang Pharmaceutical CO., LtdANDACurrent
60723-041Risedronate SodiumRisedronate SodiumHangzhou Minsheng Binjiang Pharmaceutical CO., LtdANDACurrent